News
SBNS 2025 Briefing Part 2 - Neodura™ in Paediatric duroplasty
2025.10.13

1.Meeting Information


On 26 September 2025, Day 3 of SBNS 2025 at Ashton Gate Stadium, Bristol, the 08:30 industry breakfast sponsored by Severn Healthcare focused on Medprin Dural Patches the UK experience.” 


The session was chaired by Nigel Mendoza and Sam Hattige. Two speakers shared UK data and experience: Kevin ONeil (Imperial College Healthcare NHS Trust & Cleveland Clinic London) presented 10 YearsExperience with ReDura,followed by William Singleton (Bristol Royal Hospital for Children & UHBW) on paediatric duroplasty (reported separately).


未命名.jpg 

In Part I, Kevin ONeil distilled a decade of UK practice into a closure logic that is suturable, watertight, low-adhesion and revision-friendlyelevating the patch from a product choiceto a pressure-aware, corridor-specificstrategy. Building directly on that foundation, William Singleton moved into paediatrics, where smaller anatomy, fragile tissue and tighter CSF margins demand that material properties be embedded in a pathway of care to achieve reproducible outcomes.

 

图片1.png


2.Utility of Neodura duroplasty in paediatric neurosurgical practice 

Paediatric duroplasty is rarely solved by a patch-only optimum.The centre of gravity shifts to a pathway where CSF control, closure tactics and child-specific physiology co-determine outcomes. Singletons thesis and cases illuminate this pathway-centric view. 


图片2.png


A.Core message


The problem and the solution: Children frequently present CSF circulation issues and gravity-related risks, while native tissue is limited. Plan for watertight closure from the outset, use native tissue without tension whenever feasible, divert/control CSF, and manage posture/gravity for a period post-op. No substitute can overcome persistent CSF under pressure behind the repairclosure must be designed together with CSF management. 


Why NeoDura: Singleton reported experience with NeoDura(a PLLAporcine gelatin composite). With the same synthetic backbone as ReDura, the gelatin component confers more flexibility and dura-likesuturability, being thin, tear-resistant, non-swelling on rehydration, and usable for both inlay/underlay sutured repair and onlay cover, simplifying logistics. 


Microstructure and integration: Slides illustrated an ECM-mimicking architecture, aiming for rapid regeneration and reduced foreign-body sensation. 


B.Cases


Case A | Large posterior fossa defect after tumour surgery: Dura cut and sutured + Sealant

To achieve exposure, a sizeable dural loss was inevitable. A template was fashioned; continuous suturing pursued watertightness; CSF diversion strategy implemented. To mitigate occult ooze,Singleton used a belt-and-braces approach: sutured repair plus onlay cover and selective sealant, which reduced posterior-fossa CSF leaks in his series. The lesson: control CSF first, then close. 


未命名1.jpg


Case B | Multiple pinholes after midline callosotomy: Dura onlay

With bridging/jural veins in the field, point-by-point suturing can threaten venous injury. ingleton prefers an onlay to create a watertight barrier without passing needles near a large draining vein; follow-up showed stable closure.


图片8.png 

Case C | Lipomyelomeningocele/myelomeningocele reconstruction (recent case without pictures readily available):

In dysraphic spines, reconstruction trumps resection in complexity. Where fascia is limited and mobile scars confound closure, a thin, suturable, non-swelling patch rapidly reconstitutes the barrier, helping reduce persistent leaks and shunt dependence. 


C.Perfect repairaccording to the surgeon 

  • The perfect dura is dura: use native dura whenever possible; when not, a substitute should offer suturable handling, integration, and reliable availability.

  • One material for both inlay and onlay streamlines practice and team consistency.

  • Availability matters: long-term access to the same product enables a repeatable learning curve and unit pathway.

 

3.Post-talk discussion highlights

The discussion anchored the pathway view in real-world breadth, clarifying safety signals and potential extensions of use. 

  • Spinal indications

Although detail cases not formally presented, in-room polling showed several experts already using the patch in spinal settings with positive feedback, hinting at broader applicability to spinal duroplasty.


  • Endoscopic skull-base reconstruction

Many discussants considered it a good fit, where a thin, suturable, low-adhesion patch supports controlled closure in narrow, layered corridors.


  • Integration and redo surgery

Multiple remarks pointed to excellent PLLA integration. At redo, surgeons often saw regenerated coverage with no visible patch and clear dissection planes that support safe re-entry.


  • Sometimes better than native durafor suturing

In selected re-suturing contexts, substitutes appeared less prone to tearing than native duraan instructive, counter-intuitive observation underscoring the importance of edge quality for long-term watertightness.


  • Infection signal

No infections were reported by participants; consensus favoured an extremely low infection rate, reinforcing usability in both routine and high-risk closures. 


4.Distilled conclusion (synthesising Part I + Part II + discussion)

This session reframed dural repair from finding a good patchto building a reliable pathway.” 


  • ONeils decade of UK practice showed that in large defects, high CSF gradients and revisions, balanced attributesstrength and watertightness, low adhesion with re-entry friendliness, and acceptable costgovern durable outcomes.


  • Singletons paediatric lens locked in the missing piece: without CSF control, posture/gravity management and standardised suturing, even the best patch can leak.


  • Discussion added real-world momentum: expanding confidence in spine and endoscopic skull-base, strong PLLA integration with redo-friendly planes, extremely low infection, and in certain scenarios a suturing edge that rivals native dura. 


For practising surgeons, the actionable message is brief: choose one thin, truly suturable, non-swelling, low-adhesion patch that works for sutrue, inlay and onlaythen embed it in a unit pathway of CSF control and watertight suturing. Only pathways make closures predictable.